Aptamer-Based Detection of Disease Biomarkers in Mouse Models for Chagas Drug Discovery

Bioluminescence imaging of chronicTrypanosoma cruziinfections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection

(2014) Michael D. Lewis et al.   CELLULAR MICROBIOLOGY

In silico approach for the identification of immunological properties of enolase from Trypanosoma cruzi and its possible usefulness as vaccine in Chagas disease

(2014) Alejandro Carabarín-Lima et al.   PARASITOLOGY RESEARCH

Aptamer Based, Non-PCR, Non-Serological Detection of Chagas Disease Biomarkers in Trypanosoma cruzi Infected Mice

(2014) Rana Nagarkatti et al.   PLoS Neglected Tropical Diseases

VNI Cures Acute and Chronic Experimental Chagas Disease

(2013) Fernando Villalta et al.   JOURNAL OF INFECTIOUS DISEASES

In vivo imaging of trypanosomes for a better assessment of host–parasite relationships and drug efficacy

(2013) S. Goyard et al.   PARASITOLOGY INTERNATIONAL

Antigenicity and Diagnostic Potential of Vaccine Candidates in Human Chagas Disease

(2013) Shivali Gupta et al.   PLoS Neglected Tropical Diseases

Immunosuppression and Chagas Disease: A Management Challenge

(2013) María-Jesús Pinazo et al.   PLoS Neglected Tropical Diseases

Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects

(2012) Eric Dumonteil et al.   Expert Review of Vaccines

Development of an Aptamer-Based Concentration Method for the Detection of Trypanosoma cruzi in Blood

(2012) Rana Nagarkatti et al.   PLoS One

Fexinidazole: A Potential New Drug Candidate for Chagas Disease

(2012) Maria Terezinha Bahia et al.   PLoS Neglected Tropical Diseases

Update in treatment of Chagas disease

(2011) Guillaume Le Loup et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Methodological advances in drug discovery for Chagas disease

(2011) Juan M Bustamante et al.   Expert Opinion on Drug Discovery

IL-10 Limits Parasite Burden and Protects against Fatal Myocarditis in a Mouse Model of Trypanosoma cruzi Infection

(2011) E. Roffe et al.   JOURNAL OF IMMUNOLOGY

Drug Developers Finally Take Aim at a Neglected Disease

(2011) M. Leslie   SCIENCE

In vitro and in vivo experimental models for drug screening and development for Chagas disease

(2010) Alvaro José Romanha et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

(2009) J Antonio Marin-Neto et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

The MHC Gene Region of Murine Hosts Influences the Differential Tissue Tropism of Infecting Trypanosoma cruzi Strains

(2009) Jorge M. Freitas et al.   PLoS One

Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease

(2008) Juan M Bustamante et al.   NATURE MEDICINE